Comparative Analysis of the Efficacy and Safety of PreserFlo MicroShunt and Trabeculectomy in Glaucoma Management: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Outcomes and Influencing Factors - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Analysis of the Efficacy and Safety of PreserFlo MicroShunt and Trabeculectomy in Glaucoma Management: A Systematic Review, Meta-Analysis, and Meta-Regression of Clinical Outcomes and Influencing Factors

  • By

  • Yousef Mesaed Al-Shammari

  • Abdulaziz Alotaibi

  • Basel Bader Alkharraz

  • Saddik Haddad

  • Hasan Alshawaf

  • March 19, 2026

Share

  • 1

    Glaucoma is a major cause of irreversible blindness, with intraocular pressure (IOP) reduction being the only modifiable risk factor.

  • 2

    Trabeculectomy is the most common glaucoma surgery, effective in lowering IOP but associated with significant postoperative complications.

  • 3

    The PreserFlo MicroShunt represents a minimally invasive surgical option aimed at reducing risks compared to traditional trabeculectomy.

  • 4

    This systematic review and meta-analysis evaluated the efficacy and safety of PreserFlo MicroShunt versus trabeculectomy in glaucoma patients.

  • 5

    Primary outcomes included postoperative IOP, IOP reduction, surgical success rates, and safety outcomes such as postoperative complications.

Original Source(s)

Related Content